Case Report
78 Month Experience in Sealing of Truncal Varicose Veins: A Follow-Up Study Conducted on 2162 Truncal Saphenous Veins in 1161 Cases
U Th Zierau*
Corresponding Author: Dr. Ulf Th Zierau, Department of Medical Vascular Surgery, Vein Care Center, Saphenion, Friedrichstrasse 95, 10117 Berlin, Germany
Received: February 04, 2018; Revised: September 10, 2019; Accepted: February 27, 2019
Citation: Zierau UT. (2019) 78 Month Experience in Sealing of Truncal Varicose Veins: A Follow-Up Study Conducted on 2162 Truncal Saphenous Veins in 1161 Cases. Int J Surg Invasive Procedures, 2(3): 52-57.
Copyrights: ©2019 Zierau UT. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share :
  • 259

    Views & Citations

The paper is about long-time experiences in sealing truncal varicose veins: 78 month follow up in the treatment of 1161 cases and 2162 truncal varicose veins. Since 20 years by now, varicosis has been increasingly treated endovenously. At the start, the rather inconvenient VNUS® Closure plus - procedure and the more convenient linear laser procedure were used and these were followed in 2006/2007 by the bipolar RFITT® catheter, the VNUS® closure fast system and the radial laser. Thus, in the course of the last few years, plenty of experience has been gathered with endoluminal therapy, quality criteria have been defined and standards for the different techniques have been developed.

The present research paper sheds light on the advantages and disadvantages and presents the 78 month results of a single-center praxis study with a prospective design.

We will report about our experiences and results of a prospective comparative study of VenaSeal® - Closure in the treatment of 2162 saphenous veins (1492 GSV, 550 SSV, VSAL in 63 cases, VSAM in 40 cases, Giacomini’s vein in 2 and femoropopliteal vein in 4 cases). Treatment included also lower leg ulcers in 12 cases.

INTRODUCTION

In the base, all varicose veins should be treated actively. This we can find in nearly all guidelines worldwide. All the specialists know that mobilization and compression alone cannot normalize the venous function of outflow venous blood from the leg. An insufficient varicose vein is working like a downpipe - the blood pressure at the lower leg is increased chronically. And so we get the typical chronic venose disease. Nearly 70% of all adults in Europe have clinical signs of this CVD (Figure 1)Since 19 years by now, varicosis has been increasingly treated endovenously. Before this, the varicose veins were treated radically with the “stripping” - method, a 112 years old radical surgery method.

At the start, the rather inconvenient VNUS® Closure Plus procedure and the more convenient linear laser procedure were used and these were followed in 2006/2007 by the bipolar RFITT® catheter, the VNUS® ClosureFast system, and the radial laser. Thus, in the course of the last few years, plenty of experience has been gathered with endoluminal therapy, quality criteria have been defined and standards for the different techniques have been developed [1-7].

One very important technical development combined with the beginning of the endovenous therapy was the color ultrasound  (duplex)  -  we  can  see  the  catheter  inside  the veins, the glue and we can control the tip of catheter, the work inside the vessel and the effects inside the body - without any radiation and without i.v. contrast agents. There is a very important fact because working with an endovenous catheter without ultrasound isn’t a fully noninvasive therapy because of using phlebography. Researchers have described exactly the sonographic appearances of common disorders of all tissues. They have worked about the high sensitivity of ultrasound in tissue diagnostics [8-10].

In addition, 16 years ago, far from the beaten tracks of radio wave and laser, the development of a fascinatingly simple, yet nevertheless highly effective method of sealing veins - the VenaSeal® closure technique - was initiated. After CE - approval had been granted in the autumn of 2011, a number of vein centers in Germany and Europe started using the VenaSeal® - system. By now, 35 centers are working successfully with the new therapy system in Germany alone. Today there is an approval in all countries, also in the USA since 2/2015 (Figure 2).

MATERIALS AND METHOD

Based on the manufacturer's application instructions, sealing with the VenaSeal® - the system was started 1-3 cm from the saphenofemoral junction, and a spot of glue was applied at intervals of 2-3 cm, depending on the diameter and the flow/the pressure of the vein. Thick branch-offs of auxiliary side branches were additionally treated with single-shot glue. The maximal diameter of treated truncal veins was 2-3 cm, also venous aneurysms, ectatic veins and perforators were treated.

The follow-up observation period in our study was up to 76 months.

The great saphenous vein was treated in 1492 cases, in 560 cases the small saphenous vein was treated and in 103 cases the trunk of an inguinal accessories vein was sealed. Two of Giacomini`s veins and four femoropopliteal veins also were treated.

VenaSeal® interventions were performed under light sedation with Dormicum or local anesthesia for venous access accompanied by music therapy, 119 patients (10.3%) didn't get any anesthesia or sedation. One patient performed pain acupuncture on herself.

All patients are given a follow-up examination by duplex sonography in the scope of a prospective study (our own quality management) on the 1st/14-30th/70-90th day as well as after 6 and 12 months. After this, we controlled every following year. Nearly all duplex sonography examinations post-intervention was done by another colleague, not by the vascular surgeon treated the truncal veins (Figure 3).

RESULTS

During the time period from 1st August 2012 to 31st January 2019 (78 months), Venaseal® was applied to achieve closure of the vein in 2162 truncal varicose veins. In 345 patients one saphenous vein was treated; in 661 patients two saphenous veins were treated; in 126 patients 3 saphenous veins were treated. In 26 cases 4 truncal veins and in two cases 5 veins, in one case 6 truncal veins were treated simultaneously.

Grade 2-3 saphenous varicosis of the GSV according to Hach, and in the case of the SSV and acc. saphenous varicose veins grade 2 to Hach, was the inclusion criterium. In accessory veins, we treated the inguinal trunk in length between 15-30 cm.

On the 1st day, all 2162 veins were checked (2147 veins were closed initially=99.31%) in the scope of follow-up and up to the 30th day, partial recanalization was found in 41 veins and complete recanalization was found in 10 veins. This corresponds to a closure rate of 97.64%.

Over a time period of 3 months up to 4 months after the treatment, we were able to follow up 1627 saphenous veins (75.2% of all veins that had been treated) and here we found 43 partial and 16 complete recanalizations. The closure rate is thus 97.27%.

In 1408 saphenous veins (65.1%) were followed up over a 6-8 month time period and 50 partial and 29 complete recanalizations were found, resulting in the effectiveness of 96.35% (Figure 4).

No further recanalizations were found after 78 months.

In the follow-up period of 5 years after therapy we controlled 1255 truncal varicose veins (58.0%) up to now.

All 12 leg ulcers were healed until to 12 weeks after intervention.

2162 truncal varicose veins having been sealed with Venaseal®, the results achieved over the entire time period of 78 months are equivalent to a closure rate of 96.35%.

The pain score (range 1-10) for subjectively felt pain on the 1st day post - sealing was between 1.6 and 3.4 (2.1) - in RFITT between 3.8 and 4.1.

In 174 treated veins (7.9%), we observed a postoperative unspecific inflammatory skin reaction after approx. 10-14 days in the Venaseal group; with appropriate antiphlogistic treatment with ibuprofen and ethanolic cooling bandages, this subsided within 3-5 days.

In all other cases subjected to follow-up examinations, no complications of any kind, no paresthesias or hypesthesias, no permanent skin reactions, no phlebitis or thrombosis or infections were observed. Only in 11 cases, we have seen a lymphatic fistula at the peripheral punction.

In particular, even subcutaneously situated saphenous veins could be glued without any significant skin reaction (reddening, swelling).

We also clearly prefer Sealing in the treatment of SSV and now also in GSV due to a large number of neurological sensations in connection with treatment by Laser and Radiofrequency [11,12] (Figures 5 and 6).

Nearly all patients were greatly surprised at the fully ambulatory intraoperative procedure and the brief and pleasant postoperative convalescence phase.

All patients were able to leave the office between 30 and 120 min after the intervention.

In the case of non-tumescent, non-thermal sealing we have up to now refrained from applying compression therapy in over 95% of all cases. We prefer to use compression stockings only in cases, the diameter of the treated vein is over 1.5 cm or in the treatment of a venous aneurysm or ectatic varicose veins.

DISCUSSION

In the last 20 years, the necessary quality criteria for endovascular interventions on veins with varicose changes were largely laid down, and several comparative studies on functional efficiency of radical stripping surgery on the one hand and endovenous treatments, on the other hand, were furthermore conducted. By now, it has emerged as an undeniable fact that endovenous interventions do not only exhibit a merely cosmetic advantage as was hitherto assumed. They also have clinical advantages and quite significantly reduce side effects and complications such as still occur regularly today as in the past in connection with the conventional surgical technique.

Thus, the colleagues who work with endovenous procedures meanwhile have reliable criteria for a high - quality therapy [1,4,6,12-16].

The VenaSeal® - closure procedure is the newest technical development in the series of endovenous therapeutic procedures. Although it is a catheter-based procedure in terms of the basic principle of the therapeutic approach, it differs fundamentally with regard to the closure technique. While the glue likewise gives rise to a certain temperature (approx. 45-50°C), the procedure is not a thermal one. Side effects as those known to occur in connection with laser and radio wave therapy ultimately play no significant role here. The necessary reliable closure is achieved by means of non-tumescent non-thermal cyanoacrylate superglue, the basic chemical formula of which has been known since several decades, and which is being used in neuroradiology in the treatment of vascular malformations since 1981. We also worked with this glue since 1988 in vascular surgery at the Charitè hospital.

By the way - the sealing therapy is not a new idea - also in the Golden Twenties, German surgeons and phlebologists were sealing truncal varicose veins with glucose solution. Also, the world known surgeon Ferdinand Sauerbruch was a friend of sealing, Since 1928/1929 all patients in Sauerbruch`s hospital Charitè Berlin, treated by truncal varicose veins, were sealed [17].

We do not need anesthesias anymore and can in most cases do without postoperative compression therapy. Elastic stockings should nevertheless, by all means, be recommended after the treatment of thicker saphenous varicose veins measuring >1.2 cm and they become compulsory where we intend to apply sealing therapy in larger lumens measuring 1.5 cm and more, ectatic veins, junction aneurysms and also perforator veins.

The significantly reduced side effects and a well - nigh negligible pain score are also clear advantages in comparison with laser and radio wave therapy. No paresthesias, no hypesthesias, no phlebitis, the extremely rare occurrence of skin pigmentations are only a few of the important advantages of the VenaSeal® - procedure.

In the final analysis, the new procedure has to meet solely the hard criterion of efficacy, namely the permanence of an effective vein closure. And as far as this aspect is concerned, both the first results of the eSCOPE study [15] and the results of single-center studies and also currently of the VeClose study [14] are very good. The closure rate is similarly high as that achieved with radio waves, namely between 93-100% when all results are summarized.

Thus, the Sealing procedure appears to be on the same level with, or even superior to the high-frequency radio wave system [5,18]. In the time periods between 12 and 36 months covered by follow-up examinations up to now, both procedures have proven quite clearly superior (99.6%) [13,15,18] to laser therapy in terms of effectiveness.

The results of first comparative studies show that the vein glue is clearly superior with regard to postoperative side effects though. Both the pain score and the rate of side effects are very low in comparison [12]. Particularly pain, as well as the neurological side effects, no longer plays any significant role at all. These are the main problem associated with laser and radio wave therapy though, especially in the therapy of lower leg veins like SSV (Figure 7).

By now, VenaSeal® has undeniably become at SAPHENION the therapy of the first choice for the treatment of the SSV. Here, we meanwhile consider the well-known risk of neurological side effects and complications associated with the application of the laser and radio frequency techniques as being too high [3-6,13-15,18].

In the light of the 18 years of experience, we have gathered by now, we recommend that every vein center that applies endovenous treatment should have at least 2 alternative treatment procedures at its disposal. For us, this means that in practical work with VenaSeal®, all insufficient saphenous veins should as far as possible always be treated in one session.

Independently of this and including all experiences with modifications of the sealing technique we at SAPHENION® meanwhile regard the non-tumescent, non-thermal Sealing Therapy as treatment of the first choice in the range of catheter - supported therapeutic procedures in truncal varicose veins GSV, SSV or VSAA - varicosis.

And we see this method as a very good method also in ultrasound-guided treatment of aneurysmatic and receive junctions and perforator veins.

CONFLICT OF INTERESTS

There are no conflicts of interest; the present research paper was not sponsored.

1.       Creton D, Rea B, Pittaluga P, Chastanet S, Allaert FA (2011) Evaluation of the pain in varicose vein surgery under tumescent local anesthesia using sodium bicarbonate as excipient without any intravenous sedation. Phlebology 27: 368-373.

2.       Elias S, Raines JK (2012) Mechanochemical tumescent less endovenous ablation: Final results of the initial clinical trial. Phlebology 27: 67-72.

3.       Huisman LC, Bruins RMG, van den Berg M, Hissink RJ (2009) Endovenous laser ablation of the small saphenous vein: prospective analysis of 150 patients, a cohort study. Eur J Vasc Endovasc Surg 38: 199-202.

4.       Almeida JI, Javier JJ, Mackay EG, Bautista C, Cher DJ, et al. (2012) Two-year follow up of first human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. Phlebology 20: 397-404.

5.       Proebstle TM, Vago B, Alm J, Göckeritz O, Lebard C, et al. (2008) Treatment of the incompetent great saphenous vein by endovenous radiofrequency-powered segmental thermal ablation: First clinical experience. J Vasc Surg 47: 151-156.

6.       Proebstle TM, Alm J, Rasmussen L, Dimitri S, Whiteley M, et al. (2012) Cyanoacrylate adhesive for treatment of great saphenous vein incompetence without tumescent anesthesia and without compression therapy abstract. American College of Phlebology Annual Meeting 2012 Hollywood, Florida.

7.       Rosen RJ, Contractor S (2004) The use of cyanoacrylate adhesives in the management of congenital vascular malformations. Semin Interv Radiol 21: 59-66.

8.       Abdel Razek AA, Al Belasy F, Ahmed W, Haggag M (2015) Assessment of articular disc displacement of temporomandibular joint with ultrasound. J Ultrasound 18: 159-163.

9.       Razek AA, Fouda NS, Elmetwaley N, Elbogdady E (2009) Sonography of the knee joint. J Ultrasound 12: 53-60.

10.    Razek AA, El-Basyouni SR (2016) Ultrasound of knee osteoarthritis: interobserver agreement and correlation with Western Ontario and McMaster Universities Osteoarthritis. Clin Rheumatol 35: 997-1001.

11.    Zierau UTh (2014) VenaSeal® - Therapie bei SAPHENION - 18 Monats - Ergebnisse an 379 Stammvenen; Vortrag auf dem 2. Symposium zur VenaSeal® - Closure-Therapie, Mainz.

12.    Zierau UTh (2016) Venenverklebung versus radiofrequenztherapie bei Varicosis - Verlaufsstudie über 36 Monate mit 1139 Behandlungen. Vasomed 28: 212-216.

13.    Gibson K, Morrison N, Kolluri R, Vasquez M, Weiss R, et al. (2018) Twenty four month results from a randomized trial of cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord 6: 606-613.

14.    Morrison N, Kathleen G (2014) Veclose study: Preliminary month 1 data. 2nd Annual Cyanoacrylate Embolization Symposium Mainz.

15.    Proebstle TM, Alm J, Rasmussen L, Dimitri S, Lawson JA, et al. (2013) The European multicenter study on cyanoacrylate embolization of refluxing great saphenous veins without tumescent anaesthesia and without compression therapy. eScope – study Abstract presented to the American Venous Forum Annual Meeting 2013, Phoenix (AZ), USA.

16.    http://www.saphenion.de/news/konsensus-1-neef-endovenoese-krampfadertherapie/ 

17.    ZierauU Th.h, Lahl W (2018) The fate of “Saphena” - Views into the past. J Vasc Endovasc Ther 4: 23.

18.    Rasmussen LH, Bjoern L, Lawaetz M, Lawaetz B, Blemings A, et al. (2010) A randomised clinical trial comparing endovenous laser ablation withthe stripping of the great Saphenous vein: Clinical outcome and recurrence after 2 years. Eur J Vasc Endovasc Surg 39: 630-635.